1. Home
  2. MIST vs SILC Comparison

MIST vs SILC Comparison

Compare MIST & SILC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • SILC
  • Stock Information
  • Founded
  • MIST 2003
  • SILC 1987
  • Country
  • MIST Canada
  • SILC Israel
  • Employees
  • MIST N/A
  • SILC N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • SILC Computer Manufacturing
  • Sector
  • MIST Health Care
  • SILC Technology
  • Exchange
  • MIST Nasdaq
  • SILC Nasdaq
  • Market Cap
  • MIST 89.8M
  • SILC 83.2M
  • IPO Year
  • MIST N/A
  • SILC 1994
  • Fundamental
  • Price
  • MIST $1.71
  • SILC $15.26
  • Analyst Decision
  • MIST Strong Buy
  • SILC Hold
  • Analyst Count
  • MIST 2
  • SILC 2
  • Target Price
  • MIST $7.50
  • SILC N/A
  • AVG Volume (30 Days)
  • MIST 658.4K
  • SILC 8.7K
  • Earning Date
  • MIST 08-07-2025
  • SILC 07-28-2025
  • Dividend Yield
  • MIST N/A
  • SILC N/A
  • EPS Growth
  • MIST N/A
  • SILC N/A
  • EPS
  • MIST N/A
  • SILC N/A
  • Revenue
  • MIST N/A
  • SILC $58,134,000.00
  • Revenue This Year
  • MIST N/A
  • SILC $6.26
  • Revenue Next Year
  • MIST N/A
  • SILC $19.14
  • P/E Ratio
  • MIST N/A
  • SILC N/A
  • Revenue Growth
  • MIST N/A
  • SILC N/A
  • 52 Week Low
  • MIST $0.63
  • SILC $11.35
  • 52 Week High
  • MIST $2.75
  • SILC $18.24
  • Technical
  • Relative Strength Index (RSI)
  • MIST 60.15
  • SILC 59.12
  • Support Level
  • MIST $1.67
  • SILC $14.55
  • Resistance Level
  • MIST $1.80
  • SILC $15.50
  • Average True Range (ATR)
  • MIST 0.08
  • SILC 0.51
  • MACD
  • MIST -0.01
  • SILC 0.05
  • Stochastic Oscillator
  • MIST 43.24
  • SILC 100.00

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About SILC Silicom Ltd

Silicom Ltd designs and manufactures networking and data infrastructure solutions for various servers, server-based systems, and communications devices. Its product categories consist of Server Adapters, Edge Networking Solutions, FPGA-Based Cards, x86 Open Appliances, Bypass Switches, and TAPs. Geographically, it derives a majority of its revenue from North America and also has a presence in Europe and Asia-Pacific.

Share on Social Networks: